Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes

Bone

Volumn 48, Issue 4, 2011, Pages 720-725

  Kanazawa, Ippei ^a   Yamaguchi, Toru ^a   Tada, Yuko ^a   Yamauchi, Mika ^a   Yano, Shozo ^a   Sugimoto, Toshitsugu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

HOMA; Insulin resistance; Insulin secretion; Osteocalcin; Type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; OSTEOCALCIN;

ADULT; AGE; ARTICLE; BODY FAT; BODY MASS; CELL FUNCTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; POSTMENOPAUSE;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OSTEOCALCIN;

EID: 79952698270     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.12.020     Document Type: Article

References (37)

1. Thomas D.M., Hards D.K., Rogers S.D., Ng K.W., Best J.D. Insulin and bone, clinical and scientific view. Endocrinol Metab North Am 1997, 4:5-17.
2. Ogata N., Chikazu D., Kubota N., Terauchi Y., Tobe K., Azuma Y., et al. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest 2000, 105:935-943.
3. Akune T., Ogata N., Hoshi K., Kubota N., Terauchi Y., Tobe K., et al. Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J Cell Biol 2002, 159:147-156.
4. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Yano S., Sugimoto T. Adiponectin is associated with changes in bone markers during glycemic control in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009, 94:3031-3037.
5. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Yano S., Sugimoto T. Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur J Endocrinol 2009, 160:265-273.
6. Richards J.B., Valdes A.M., Burling K., Perks U.C., Spector T.D. Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab 2007, 92:1517-1523.
7. Kanazawa I., Yamaguchi T., Yano S., Yamauchi M., Yamamoto M., Sugimoto T. Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol 2007, 8:51.
8. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
9. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Kurioka S., Yano S., et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009, 94:45-49.
10. Kanazawa I., Yamaguchi T., Yamauchi M., Yamamoto M., Kurioka S., Yano S., et al. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 2011, 22:187-194.
11. Fernandez-Real J.M., Izquierdo M., Ortega F., Gorostiaga E., Gomez-Ambrosi J., Moreno-Navarrete J.M., et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 2009, 94:237-245.
12. Hwang Y.C., Jeong I.K., Ahn K.J., Chung H.Y. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced β-cell function in middle-aged male subjects. Diabetes Metab Res Rev 2009, 25:768-772.
13. Pittas A.G., Harris S.S., Eliades M., Stark P., Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009, 94:827-832.
14. Winhofer Y., Handisurya A., Tura A., Bittighofer C., Klein K., Schneider B., et al. Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diab Care 2010, 33:139-143.
15. Kindblom J.M., Ohlsson C., Ljunggren O., Karlsson M.K., Tivesten A., Smith U., et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res 2009, 24:785-791.
16. Im J.A., Yu B.P., Jeon J.Y., Kim S.H. Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta 2008, 396:66-69.
17. Shea M.K., Gundberg C.M., Meigs J.B., Dallal G.E., Saltzman E., Yoshida M., et al. γ-Carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr 2009, 90:1230-1235.
18. Zhou M., Ma X., Li H., Pan X., Tang J., Gao Y., et al. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol 2009, 161:723-729.
19. Kahn S.E. The relative contributions of insuloin resistance and beta-cell dysfunction to the pathophysiology of type II diabetes. Diabetologia 2003, 46:3-19.
20. Conwell L., Trost S.G., Brown W.J., Batch J.A. Indexes of insulin resistance and secretion in obese children and adolescents: validation study. Diab Care 2004, 27:314-319.
21. Sinha R., Fisch G., Teague B., Tamborlane W.V., Banyas B., Allen K., et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002, 346:802-810.
22. Report of the Committee of Japan Diabetes Society on the classification and diagnostic criteria of diabetes mellitus. J Japan Diab Soc 1999, 42:385-404. [in Japanese].
23. Ferron M., Hinoi E., Karsenty G., Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008, 105:5266-5270.
24. Oh K.W., Lee W.Y., Rhee E.J., Baek K.H., Yoon K.H., Kang M.I., et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol 2005, 63:131-138.
25. Pajvani U.B., Hawkins M., Combs T.P., Rajala M.W., Doebber T., Berger J.P., et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004, 279:12152-12162.
26. Waki H., Yamauchi T., Kamon J., Ito Y., Uchida S., Kita S., et al. Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. J Biol Chem 2003, 278:40352-40363.
27. Nishizawa H., Shimomura I., Kishida K., Maeda N., Kuriyama H., Nagaretani H., et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002, 51:2734-2741.
28. Yamaguchi T., Kanazawa I., Yamamoto M., Kurioka S., Yamauchi M., Yano S., et al. Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Bone 2009, 45:174-179.
29. Choi H.S., Kim K.J., Kim K.M., Hur N.W., Rhee Y., Han D.S., et al. Relationship between visceral adiposity and bone mineral density in Korean adults. Calcif Tissue Int 2010, 87:218-225.
30. Fujimoto W.Y. Overview of non-insulin-dependent diabetes mellitus (NIDDM) in different population groups. Diabet Med 1996, 13:S7-S10.
31. Torrens J.I., Skurnick J., Davidow A.L., Korenman S.G., Santoro N., Soto-Greene M., et al. Ethnic differences in insulin sensitivity and beta-cell function in premenopaulsa or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diab Care 2004, 27:354-361.
32. Vestri H.S., Lara-Castro C., Moellering D.R., Gunberg C.M., Garvey W.T. Osteocalcin is not just for bones: effects on adipocytes and role in human metabolism. Diabetes 2008, 57:A29.
33. Prats-Puig A., Mas-Parareda M., Piera-Perez E., Gonzalez-Forcadell D., Mier C., Mallol-Guisset M., et al. Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children. Diab Care 2010, 33:661-663.
34. Karsenty G. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 2006, 4:341-348.
35. Halade G.V., El Jamali A., Williams P.J., Fajardo R.J., Fernandes G. Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. Exp Gerontol 2011, 46:43-52.
36. Xie H., Tang S.Y., Luo X.H., Huang J., Cui R.R., Yuan L.Q., et al. Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 2007, 80:201-210.
37. Thommesen L., Stunes A.K., Monjo M., Grosvik K., Tamburstuen M.V., Kjobli E., et al. Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem 2006, 99:824-834.